These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6771745)

  • 1. Chemically triggered time delay activation chemotherapy for the treatment of cancer.
    Walker EH
    Perspect Biol Med; 1980; 23(3):424-38. PubMed ID: 6771745
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antitumoral chemotherapy].
    Drochmans A
    Acta Clin Belg; 1974; 29(1):1-19. PubMed ID: 4596845
    [No Abstract]   [Full Text] [Related]  

  • 3. Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma.
    Chi KH; Chan WK; Shu CH; Law CK; Chen SY; Yen SH; Chen KY
    Cancer; 1995 Dec; 76(11):2186-92. PubMed ID: 8635020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy for ovarian cancer.
    Malkasian GD
    Med Clin North Am; 1974 Jul; 58(4):779-92. PubMed ID: 4601964
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase I study of mitozolomide on a once daily for 5 days schedule.
    Schornagel JH; Simonetti G; Dubbelman R; ten Bokkel Huinink WW; McVie JG
    Cancer Chemother Pharmacol; 1990; 26(3):237-8. PubMed ID: 2357772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized phase II trial of 5-fluorouracil, with or without human interferon-beta, for advanced colorectal cancer.
    Villar-Grimalt A; Candel MT; Massuti B; Lizón J; Sánchez B; Frau A; Gorostidi B; Goedkoop R
    Br J Cancer; 1999 May; 80(5-6):786-91. PubMed ID: 10360656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oral fluoropyrimidines in oncology].
    González Barón M
    An R Acad Nac Med (Madr); 1998; 115(3):721-45; discussion 745-6. PubMed ID: 10208021
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent developments in cancer chemotherapy.
    Jewers K
    Prog Drug Res; 1981; 25():275-360. PubMed ID: 7031765
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination chemotherapy of advanced murine myeloma and subsequent resistance to tumor cell challenge.
    Teller MN; Bowie M; Mountain IM; Stock CC
    J Natl Cancer Inst; 1974 Mar; 52(3):667-71. PubMed ID: 4857022
    [No Abstract]   [Full Text] [Related]  

  • 11. An assessment of massive-dose chemotherapy of malignant disease.
    Bergsagel DE
    Can Med Assoc J; 1971 Jan; 104(1):31-6. PubMed ID: 4322068
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
    Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of 18 months of chemotherapy with Peptichemio].
    Battelli T; Bonsignori M; Manocchi P; Perilli A
    Minerva Med; 1974 Sep; 65(62):3235-43. PubMed ID: 4609310
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of thymidine in biochemical modulation: a review.
    O'Dwyer PJ; King SA; Hoth DF; Leyland-Jones B
    Cancer Res; 1987 Aug; 47(15):3911-9. PubMed ID: 3300957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of cisplatin, 5-fluorouracil, and leucovorin in inoperable squamous cell carcinoma of the esophagus. ONCOPAZ Cooperative Group, Spain.
    Feliu J; González Barón M; García Girón C; Espinosa E; Vicent JM; Gómez Navarro J; Berrocal A; Ordóñez A; Vilches Y; de Castro J; Díaz J
    Am J Clin Oncol; 1996 Dec; 19(6):577-80. PubMed ID: 8931675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methods for optimizing cytostatic drug therapy].
    Lipp HP
    Med Monatsschr Pharm; 1995 Oct; 18(10):282-91. PubMed ID: 7476654
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of cell kinetics in cancer chemotherapy.
    Valeriote FA; Edelstein MB
    Semin Oncol; 1977 Jun; 4(2):217-26. PubMed ID: 327554
    [No Abstract]   [Full Text] [Related]  

  • 18. Docetaxel in combination with fluorouracil for advanced solid tumors.
    Burris HA
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):50-2. PubMed ID: 9364544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacology in oncology. Recent advances.
    Dodion P
    Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1499-507. PubMed ID: 6357804
    [No Abstract]   [Full Text] [Related]  

  • 20. Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review.
    Holmes FA
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):46-56. PubMed ID: 8893900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.